A study recently published in the February 2014 edition of Colorectal Disease analyzed the outcomes studies of Secca therapy in patients with fecal incontinence. Outcomes analysed included quality of life, the Wexner incontinence score, anorectal manometry and endoanal ultrasound findings. A total of 220 patients from 10 studies were included. In the majority of clinical studies, the SECCA procedure has been shown to be an effective treatment of mild-to-moderate faecal incontinence.

The study noted the therapeutic effect of RF in Secca has been related to the improvement of sphincter function and anorectal sensitivity. The authors noted that in the majority of clinical studies, Secca has been shown to be an effective treatment for mild to moderate fecal incontinence. According to these observations, a major advantage of SECCA compared with other treatments, such as bulking injections, sacral nerve stimulation (SNS) and surgery, is the relatively low morbidity.

The study concluded that when patient selection is appropriate, this treatment has demonstrated clinically significant improvements in symptoms, as demonstrated by statistically significant reductions in the Wexner incontinence and quality of life scores.